COEUS Holdings

COEUS Holdings ("COEUS") is an active US-based healthcare consultancy specializing in market access strategy and commercialization support primarily within the biopharmaceutical sector. Founded in Devon, Pennsylvania in 2009 by Marc Hixson, it has grown organically and via acquisitions—including Mirador Global—and was itself acquired by Red Nucleus in February 2025. The firm does not develop its own therapeutics but provides critical services to pharmaceutical manufacturers around product launch planning/execution—including pricing/reimbursement strategies for complex therapies like cell/gene therapies or rare diseases—and offers proprietary technology platforms such as the “COEBRA Outcomes & Evidence Platform” to manage value-based contracts/outcomes tracking. Its leadership team includes industry veterans with deep experience at major payers/pharmas. As part of its evolution under new ownership by Red Nucleus, it continues to serve leading life science organizations globally with expertise spanning HEOR strategy/execution through digital enablement/data analytics solutions tailored to maximize patient access/commercial success.